Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Clean food, gut bacteria, and drug effects: Is diet another variable drug development?

Posted on March 9th, 2017 by in Pharma R&D

There has been quite a lot of press coverage in the UK recently regarding clean eating, and a variety of recipes and websites offering advice are becoming quite popular. Continue reading “Clean food, gut bacteria, and drug effects: Is diet another variable drug development?” »

A Bright Future for Bacteria

Posted on January 3rd, 2017 by in Pharma R&D

Microbes account for about 2% of a person’s body weight. These trillions of bacteria, most of which are in the gut, are referred to as the microbiome. Continue reading “A Bright Future for Bacteria” »

Can your Microbiome Make you Fat?

Posted on November 9th, 2016 by in Pharma R&D

This is a story about fecal microbiota transplant (FMT): FMT is a procedure in which fecal matter is collected from a healthy donor and placed in a recipient, typically by colonoscopy. The purpose? Continue reading “Can your Microbiome Make you Fat?” »

Venturing into the Microbiome

Posted on September 28th, 2016 by in Pharma R&D

The growing library of bacterial genomic material and microorganisms that reside within the human host is termed the microbiome. Microbiota, a less-used term, refers to the community of single cell organisms (i.e. bacteria, fungi, virus, etc.) that inhabit us, the superhost human organism. Prior to genomic sequencing, bacterial identification occurred by laboratory isolation and culturing. Continue reading “Venturing into the Microbiome” »